Анцеф

Quick links to important sections

Анцеф

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Анцеф

What is Анцеф (Cefazolin)?

Property Description
Active ingredient Cefazolin sodium
Form Lyophilized powder for injection solution
Pharmacological class First-generation cephalosporin (Antibiotic)
Common use Fighting bacterial infections
Origin Semisynthetic

Анцеф is the trade name for a medicine whose active substance is Cefazolin sodium, a powerful agent used to treat and prevent infections caused by susceptible bacteria. It is officially classified as a first-generation cephalosporin antibiotic, placing it in the broader beta-Lactam class of antimicrobial drugs. The drug is clinically recognized for its reliability in acute care settings and is considered a reference standard in surgical prophylaxis. This indicates Cefazolin is a reliable, established choice in professional medical practice.


What Type of Medicine is Анцеф (Cefazolin)?

Cefazolin is a semisynthetic drug, derived from natural starting materials but chemically modified to enhance its stability and effectiveness against bacterial pathogens. Its primary mode of action is bactericidal—it directly kills the bacteria by interfering with their ability to build and maintain a strong protective cell wall. This mechanism makes it highly effective against a wide range of common bacteria, particularly those known as Gram-positive organisms. This classification reflects the drug's importance, safety, and cost-effectiveness in global public health. Cefazolin is a prescription-only (Rx) medication, reflecting its critical role in managing serious infections.


Composition and Form: Why Анцеф is Prepared as a Powder for Injection

The active component, Cefazolin sodium, is a single-ingredient product typically supplied as a lyophilized powder for solution for injection. This means the drug is stored in a sterile, dry form in a vial and must be mixed with a compatible sterile diluent, such as sterile water, just before use. This formulation dictates its method of delivery, which is parenteral administration (injection into a vein or muscle). Unlike oral antibiotics, this rapid delivery is a key differentiator that supports its primary role in urgent care and infection management where quick onset of action is critical.

What side effects are possible with Анцеф?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and regulatory safety information for Анцеф (cefazolin), derived from authoritative government sources. It is not instructional and does not include dosing or therapeutic uses.

Safety Profile Overview

Safety data categorizes reactions by frequency and severity, focusing on potential harm to specific body systems. Key safety limitations include contraindications and the potential for severe adverse events.

Adverse Reactions by Frequency

Classification Example Adverse Reaction
Common (1%–10%) Diarrhea, pain at intramuscular injection site.
Uncommon (0.1%–1%) Thrombophlebitis with intravenous administration.
Rare (0.01%–0.1%) Neutropenia, Leukopenia (blood disorders).
Frequency Not Known Anaphylaxis, Seizures, Pseudomembranous Colitis, Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN).

Serious Safety Considerations

The most serious documented reactions include life-threatening anaphylaxis and other severe hypersensitivity reactions. High doses, particularly in patients with renal impairment (kidney function issues), have been associated with seizures. Treatment may cause Clostridioides difficile-associated Diarrhea (CDAD), which can range from mild to fatal colitis. Skin and Subcutaneous Tissue disorders, such as SJS and TEN, are also reported.

Safety-Related Restrictions

Contraindications: Анцеф is contraindicated (should not be used) in individuals with a known allergy or history of immediate hypersensitivity to cefazolin, any cephalosporin, penicillin, or other beta-lactam antibacterial drugs. Caution is required in patients with a history of gastrointestinal disease, especially colitis.

Population-Specific Notes: Dosage adjustments are required for patients with impaired renal function to prevent excessive drug levels and potential seizure risk. Positive direct and indirect antiglobulin (Coombs) tests have been reported in neonates whose mothers received cephalosporins prior to delivery.

Overdose and Emergency Response

Overdose and When to Seek Help

The information regarding Cefazolin (Анцеф) overdosage is based strictly on descriptions provided in official government regulatory documents.

Documented Overdose Manifestations

Element Regulatory Statement
Documented Manifestations Clinical presentations include signs of Central Nervous System (CNS) toxicity, such as seizures (convulsions), headache, and paresthesia (Source: Regulatory Labeling).
Associated Risk Factor Patients with impaired renal function are at a heightened risk for CNS toxicity due to reduced clearance, particularly if inappropriately high doses are administered (Source: Regulatory Labeling).

Emergency Actions and Required Interventions

Element Regulatory Statement (Action Mandated)
Immediate Help Required Seek immediate medical attention or call emergency services immediately if severe symptoms such as collapse, a seizure, trouble breathing, or inability to be awakened occur (Source: Regulatory Guidance).
Antidote Information No specific antidote is known for Cefazolin overdose (Source: Regulatory Labeling).
Supportive Measures Management involves providing symptomatic and supportive treatment. Hemodialysis may be considered in severe cases as a means to remove the drug from circulation (Source: Regulatory Labeling).

Summary of Regulatory Profile

The official overdose profile for Cefazolin emphasizes the risk of CNS toxicity, with seizures being the most severe outcome, especially when compounded by kidney impairment. The guidance mandates that individuals experiencing these severe, life-threatening symptoms must immediately contact emergency medical help, as standard treatment focuses on providing necessary supportive care.

Therapeutic Uses of Анцеф

Cefazolin may be part of symptomatic management and is commonly used when symptoms related to susceptible bacterial infections create noticeable physiological strain and require short-term, supportive assistance. The therapeutic use of Cefazolin is generally applied in acute and serious clinical settings.

Clinical use covers critical areas including infection treatment and prevention.

What Анцеф Treats: Main Uses and Benefits

Cefazolin is applicable within clinical settings that involve acute or disruptive symptom patterns, such as septicemia (bloodstream infection), endocarditis (heart valve infection), and infections of the bone and joints (like osteomyelitis). It is also relevant in contexts marked by increased discomfort or tension associated with localized inflammation in the skin and soft tissues (cellulitis), the biliary tract, and certain urinary tract infections.

In acute scenarios, Cefazolin helps address symptom clusters that may become intense or disruptive, specifically high fever, chills, localized pain, and swelling.

“The therapeutic action provides support that helps ease the overall symptom burden and contributes to improved comfort during symptomatic periods.”

A key benefit is its use in preventative care around surgical events, where it is applied in scenarios where additional management of discomfort is required to reduce the likelihood of infection during major procedures like open-heart surgery. This preventative support may assist with maintaining functional stability by mitigating the risk of serious postoperative infections.


Quick Fact: Supports managing Localized Pain and Swelling

Regulatory References

  1. NIH DailyMed Prescribing Information for Cefazolin

Eligibility and Restrictions for Use

Who Can and Cannot Use Анцеф (Cefazolin): Official Eligibility

The eligibility for Cefazolin is defined by strict regulatory criteria governing patient population, pre-existing conditions, and physiological status.

Contraindications (Absolute Prohibition)

Cefazolin is contraindicated in patients with a documented history of hypersensitivity to Cefazolin itself, to the cephalosporin class of antibacterial drugs, or a history of severe immediate-type allergic reactions to penicillins or other beta-lactam drugs.

Age-Related Eligibility

The medicine is generally approved for use in adults and pediatric patients starting from one month of age. Use in infants younger than one month is not established due to a lack of safety and effectiveness data. Geriatric patients are eligible, but monitoring for age-related renal function changes is advised.

Condition-Based Restrictions (Conditional Use)

Use requires caution and is restricted in patients with impaired renal function, as dosage must be adjusted according to calculated creatinine clearance to prevent drug accumulation and potential seizures. Caution is also advised for patients with a history of colitis or other gastrointestinal disease.

Pregnancy and Lactation Status

The medicine is classified as Pregnancy Category B; it should be used during pregnancy only if clearly needed. Cefazolin is excreted in low concentrations in human milk, meaning use is conditional and requires caution during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific constraints and requirements when using Анцеф (Cefazolin) concurrently with other medicinal products and substances. These interactions generally fall into three categories: altered drug concentrations, increased risk of adverse effects, and interference with laboratory tests.


Documented Pharmacokinetic and Pharmacodynamic Interactions

Interacting Product Category Official Interaction Implication
Probenecid (Uricosuric agent) Concomitant use increases and prolongs the serum concentration of Cefazolin by inhibiting its renal tubular secretion.
Anticoagulants (e.g., Warfarin) Increased risk of bleeding is documented, requiring close patient monitoring.
Nephrotoxic Agents (e.g., Aminoglycosides, Furosemide) Concurrent use is noted to increase the risk of nephrotoxicity, necessitating caution.
Live Bacterial Vaccines (e.g., Cholera, Typhoid live) Antibiotic activity may reduce the immunological effect of the vaccine; coadministration is generally avoided.

Interaction with Laboratory Tests

Cefazolin is documented to cause a false-positive direct Coombs' test. This interference must be considered when interpreting blood test results.

Mechanism of Action

Irreversible Inactivation of Bacterial Cell Wall Assembly

The primary mechanistic domain of Cefazolin involves its action as an irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), the enzymes responsible for constructing the pathogen's rigid cell wall. This specific molecular interference arrests the final stage of peptidoglycan synthesis, thereby compromising the bacteria's structural integrity.

Inducing Catastrophic Cell Lysis (Bactericidal Effect)

By blocking cell wall synthesis, Cefazolin eliminates the cell's structural defense against its own internal osmotic pressure. The physiological consequence is rapid and acute cell lysis (rupture and death) of the susceptible bacterium, which results in the drug's bactericidal effect and reduction of the pathogenic population.

️ Mechanisms of Resistance and Limitation

The drug's action is inherently constrained by bacterial defense mechanisms, including the production of beta-Lactamase enzymes that chemically destroy Cefazolin before it reaches its target, or through the structural modification of PBPs, which prevents the drug from binding effectively. Furthermore, the mechanism only operates against bacteria that are in a state of active growth and division.

Dosage and Administration Information

How to Use Анцеф (Cefazolin)

Cefazolin is supplied as a lyophilized powder that must be reconstituted with a compatible sterile diluent before administration. Due to this specialized form, it is administered via the parenteral route—primarily as an Intravenous (IV) infusion or occasionally as an Intramuscular (IM) injection. The IV administration typically occurs over approximately 30 minutes after preparation.

Official Dosing and Scheduling

Usage Context Adult Dose Range Frequency
Treatment (Normal Renal Function) 250 mg to 1.5 grams per dose Every 6 to 12 hours
Surgical Prophylaxis (Initial Dose) 1 gram to 2 grams 1/2 hour to 1 hour pre-surgery

For general treatment, dosing is determined by the severity of the infection, with the maximum daily dose reaching up to 12 grams in rare, severe cases. The prophylactic regimen is time-specific: the initial dose must be administered immediately prior to the surgical incision, and administration is generally discontinued within 24 hours post-operation.

A critical instruction for use relates to specific populations: a dose adjustment is mandatory for adult patients with renal impairment (creatinine clearance less than 55 mL/min), which requires a documented reduction in the dosage or an extension of the time interval between doses. Pediatric dosing is based on body weight (mg/kg). These instructions define the standardized, procedural approach to using the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Анцеф (Cefazolin)


Evidence for Use in Surgical Prophylaxis

Studies have extensively examined Cefazolin's use in research exploring the prevention of infection during and after surgery. This research primarily relies on systematic reviews and meta-analyses that consolidate findings from numerous randomized controlled trials (RCTs) and high-quality observational studies. The main outcomes monitored were the rates of Surgical Site Infection (SSI), which reflect outcomes related to acute or disruptive episodes that can follow an operation.

Research highlights changes measured during the study period. The accumulated evidence, as described by regulatory guidelines, showed patterns related to the monitored rates of Surgical Site Infection (SSI). Measurements were primarily short-term, focusing on outcomes tracked within the first 30 to 90 days after the surgical procedure. What remains uncertain involves the optimal approach for certain patient subsets, such as the best dosing strategies for patients with very high body weight or obesity, where guidance often relies on non-clinical data.


Evidence for Managing Serious Systemic Infections

Cefazolin was studied for managing serious systemic infections, including those in the bloodstream (bacteremia) and heart valve infections (infective endocarditis). Research includes systematic reviews of retrospective cohort studies and recent prospective comparative trials where Cefazolin was observed alongside other standard treatments. Studies monitored outcomes related to physiological strain, such as all-cause mortality and rates of treatment failure or recurrence.

Studies monitored outcomes related to systemic or functional imbalance when Cefazolin was observed alongside other anti-staphylococcal antibiotics. For endocarditis, data for certain groups remain insufficient, as the evidence is primarily derived from observational studies and the randomized controlled trials (RCTs) are limited. Additionally, there is ongoing scientific discussion regarding Cefazolin's profile when bacterial concentrations are extremely high, which may reduce its observed activity in certain complex infections.

Frequently Asked Questions (FAQ)

Common questions about Анцеф (FAQ)


Q: Is it necessary to finish the entire course of Анцеф even if I feel better?

Official information advises patients to continue using the medication until the prescription is completely finished, even if symptoms begin to improve earlier. This approach aligns with standard prescribing practices for antibiotics to reduce the risk of incomplete treatment and microbial resistance.


Q: Can I take other antibiotics at the same time as Анцеф?

Concurrent use of antibiotics and other drug categories is a matter that requires professional review. The decision regarding concurrent use of any antibiotics requires review by a healthcare professional.


Q: What happens if I stop taking Анцеф too early?

Regulatory guidance emphasizes that the full treatment course should be completed as prescribed by a healthcare professional. Stopping the medication prematurely may not lead to the intended treatment outcome and is a factor often associated with the risk of bacterial resistance or infection recurrence.


Q: Is there any official guidance on the maximum duration of Анцеф treatment?

The length of treatment is officially described as dependent on the type and severity of the infection and the patient's physiological response to the medication. For preventing infection before and during surgery (prophylaxis), use is generally discontinued within 24 hours after the operation.


Q: Is Анцеф appropriate for use during pregnancy?

The drug is officially classified in Pregnancy Category B. Official guidance indicates that use during pregnancy requires consideration of whether the potential benefit justifies the potential risks.


Q: Can older adults use Анцеф without special precautions?

Older adult patients are officially eligible for treatment. However, official information advises that special caution and dosage adjustments are often necessary if the patient has any degree of impaired kidney function, to ensure the drug level in the body remains appropriate and reduce the potential for adverse effects.


Q: Does the package insert for Анцеф contain information about patient expectations?

Official consumer information documents contain warnings about potential adverse reactions. These documents mention potential side effects, such as dizziness, which serves to inform the user about general safety precautions that may be necessary.


Q: Can Анцеф be used for different types of infections?

Yes, official indications list treatment for multiple types of susceptible bacterial infections. These include infections affecting the respiratory tract, urinary tract, skin and soft tissue, bones, joints, and systemic infections like septicemia.


Q: How quickly does Анцеф start working after the first dose?

Due to its administration by injection, the medicine is delivered directly into the bloodstream or muscle. Official patient information generally suggests that a person should begin to feel better or see improvement during the first few days of treatment as the medication begins its action.


Q: How long do the effects of Анцеф last in the body?

Official pharmacokinetic data reports that the serum half-life (a measure of time for the drug concentration to reduce by half in the blood) following intravenous administration is approximately 1.8 hours. The medication is typically administered every 6 to 12 hours to maintain effective levels.


Q: Does Анцеф interact with common over-the-counter pain relievers?

While regulatory documents list many known drug-to-drug interactions, they do not explicitly cover every single over-the-counter pain reliever. Official guidance for all medications advises that users disclose all concurrent products, including non-prescription items, for a complete interaction review.


Q: What should be done if a dose of Анцеф is missed?

For doses that may be self-administered, official guidance typically advises taking the missed dose as soon as it is remembered. However, official guidance typically states that if it is almost time for the next scheduled dose, the missed dose is usually skipped, and the regular schedule is resumed.


Q: What are the typical conditions or diseases Анцеф is officially approved to treat?

The officially approved uses include infections of the respiratory tract, urinary tract, skin and skin structure, biliary tract, bone and joints, genital infections, septicemia, and endocarditis. These indications define the range of infections the drug is cleared to manage.


Q: Does using Анцеф mean I will be protected from all infections?

No. Official documentation states that the drug's activity is limited to infections caused by susceptible bacteria. It is not effective against infections caused by viruses, fungi, or bacteria that have developed resistance to the medicine.


Q: Is Анцеф considered a broad-spectrum or narrow-spectrum antibiotic?

Cefazolin, the active ingredient, is typically described in scientific literature as having a broad spectrum of activity. This classification reflects its activity against a wide variety of bacterial pathogens, particularly those known as Gram-positive organisms.


Q: What are the official safety classifications for Анцеф?

Official safety classifications are included throughout the drug label. These include restrictions for use based on known hypersensitivity (contraindication), specific warnings regarding use in patients with renal impairment, and the designation of Pregnancy Category B.


Q: Are there research studies available that discuss the effectiveness of Анцеф?

Yes. Official drug labeling and documents reference specific clinical studies and trials that have examined the effectiveness and safety of the drug. These studies provide the evidence for the drug’s approved indications, such as its use in surgical prophylaxis.


Q: Does drinking alcohol affect the safety or effectiveness of Анцеф?

While the risk is considered low for Cefazolin, official guidance for some cephalosporins advises caution regarding alcohol use. This is due to the potential for a disulfiram-like reaction, which can cause severe vomiting and flushing.


Q: Can Анцеф cause stomach upset or digestive issues?

Yes, gastrointestinal issues are among the most common adverse reactions officially reported. These reactions may include nausea, vomiting, stomach cramps, and diarrhea.


Q: Is it normal to feel tired or weak while on Анцеф?

General tiredness or weakness is not consistently listed as a common or frequent reaction in the official safety profile. However, it has been reported with antibiotic use generally and can also be a symptom of the underlying infection being treated.


Q: Can Анцеф be used to treat viral infections?

No. Official documentation explicitly states that the medicine should only be used to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. It is not effective against viruses.


Q: Does Анцеф interact with common supplements like vitamins or herbal products?

General official guidance indicates that all products, including supplements, should be reviewed by a healthcare professional. This is to ensure the medicine can be used safely and effectively with all concurrent regimens.


Q: What does the term 'intravenous administration' mean for Анцеф?

Intravenous (IV) administration is the primary method of use for this medication. It means the medicine is injected directly into a vein, typically as an infusion over a set period of time, to ensure rapid and complete delivery into the bloodstream.


Q: What evidence exists about Анцеф's use in severe infections?

Official indications and established dosing schedules cover the management of severe, life-threatening infections. These include systemic infections like septicemia (blood infection) and infections of the heart valves, known as endocarditis.


Q: Why are some infections treated with a single dose of Анцеф and others with multiple?

Official dosing schedules reflect two separate uses. A single or very short regimen is used for perioperative prophylaxis (preventing infection around the time of surgery), while a multi-dose regimen is used for treating an existing, active infection.


Q: Does the official information mention any long-term effects of using Анцеф?

Official safety data lists adverse reactions that can occur during or shortly after treatment. While some issues, like severe diarrhea (C. difficile colitis), may occur after therapy completion, there is no explicit section defining 'long-term effects' for a typical, limited duration course.


Q: Can Анцеф affect my blood sugar levels?

Official safety reports have included rare instances of both increased and decreased blood glucose levels as an observed adverse reaction. Patients with pre-existing conditions affecting blood sugar may require monitoring.


Q: Are there foods or drinks that should be avoided while taking Анцеф?

The main substance requiring caution is alcohol, due to the potential for interaction. Because this medication is administered by injection, food intake does not typically affect the absorption of the drug.


Q: What is the meaning of the dosage strength (e.g., 1g) for Анцеф?

The dosage strength (e.g., 1 g or 500 mg) refers to the precise amount of the active ingredient, Cefazolin, that is contained in the vial or dose for injection. This measurement guides the healthcare professional in calculating the correct amount to administer.


Q: Is Анцеф used more commonly in hospitals or outpatient settings?

Given the official requirement for preparation and parenteral (IV/IM) administration, the drug's use is heavily associated with structured medical environments like hospitals and specialized clinics where sterile injection is performed.


Q: What if I experience side effects that are not listed in the official documents?

Official documentation provides dedicated mechanisms for patients and healthcare professionals to report all suspected adverse reactions. These reports, even for unlisted effects, are critical for continuous safety monitoring by regulatory agencies.


Q: Can Анцеф interfere with birth control pills?

Official interaction information suggests that antibiotics, including Cefazolin, may potentially reduce the effectiveness of estrogen-containing oral contraceptives in some patients. The official guidance on this potential interaction is a topic for professional discussion.


Q: Is there information on how Анцеф is handled by the liver?

While the drug is primarily excreted by the kidneys, safety data notes that transient elevations in liver enzymes have been observed in some patients. Rare reports of hepatitis have also been received in post-marketing surveillance.


Q: Are there any specific laboratory tests that monitor the effects of Анцеф?

Lab tests are often used by healthcare professionals to monitor important functions, such as kidney (BUN, creatinine) and liver (liver enzymes) function, during the course of treatment. These monitoring tests are conducted to assess how the body systems, such as the kidneys and liver, are responding during treatment.


Q: Does research support Анцеф being used for skin infections?

Yes, the medication is officially indicated in regulatory documents for the treatment of susceptible infections affecting the skin and skin structure. Research evidence supports its use for infections in this area of the body.

How should Анцеф be stored and disposed of?

How to Store and Dispose of Ancef (Cefazolin for Injection)

The lyophilized powder must be stored at Controlled Room Temperature ( 20 C to 25 C) and should be protected from light. The container must be kept tightly closed. The medication must always be stored out of reach of children.

Once the powder is reconstituted, its stability is limited. The solution is typically stable for 24 hours at room temperature or 72 hours under refrigeration. Frozen solutions should not be thawed using hot water or microwaves.

Disposal instructions mandate that unused or expired Cefazolin must not be flushed down the toilet. The product and container must be disposed of in accordance with all local, regional, and national regulations for pharmaceutical waste, often requiring the use of medicine take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Анцеф found in:

A-Z Index: